1. Home
  2. Analysis
  3. Xospata
  4. Cellulitis

Xospata and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Xospata (gilteritinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Cellulitis when taking Xospata. It is created by eHealthMe based on reports of 2,411 people who have side effects when taking Xospata from the FDA, and is updated regularly.

What is Xospata?

Xospata has active ingredients of gilteritinib. eHealthMe is studying from 2,411 Xospata users. Check the latest studies of Xospata.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,080 drugs and 2,339 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Aug, 09, 2026

2,411 people reported to have side effects when taking Xospata.
Among them, 16 people (0.66%) have Cellulitis.

Could Xospata cause Cellulitis?

Among these 16 people:

How long have people been on Xospata when they have Cellulitis? *

  • < 1 month: 83.33 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 16.67 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Cellulitis when taking Xospata? *

  • female: 50 %
  • male: 50 %

What is the age of people who have Cellulitis when taking Xospata? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.25 %
  • 40-49: 0.0 %
  • 50-59: 6.25 %
  • 60+: 87.5 %

What are other drugs people take besides Xospata? *

  1. Vitamin D3: 1 person, 6.25%
  2. Vidaza: 1 person, 6.25%
  3. Prednisolone: 1 person, 6.25%
  4. Hydrea: 1 person, 6.25%
  5. Fluconazole: 1 person, 6.25%
  6. Fish Oil: 1 person, 6.25%
  7. Amlodipine: 1 person, 6.25%

What are other side effects people have besides Cellulitis? *

  1. Rashes (redness): 5 people, 31.25%
  2. Thrombocytopenia (decrease of platelets in blood): 3 people, 18.75%
  3. Cough: 3 people, 18.75%
  4. Blast Cell Count Increased: 2 people, 12.50%
  5. Blood Creatine Phosphokinase Increased: 2 people, 12.50%
  6. Fever: 2 people, 12.50%
  7. Bone Marrow Failure: 2 people, 12.50%
  8. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 12.50%
  9. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 2 people, 12.50%
  10. Diarrhea: 2 people, 12.50%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 50.00%
  2. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 6 people, 37.50%

* Approximation only. Some reports may have incomplete information.

Do you take Xospata and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xospata:

Cellulitis treatments and more:

How severe was Cellulitis and when was it recovered:

Expand to all the drugs that have ingredients of gilteritinib:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xospata:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Browse all the conditions that are associated with Cellulitis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gilteritinib (the active ingredients of Xospata) and Xospata (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.